DigmBio

Website

Developer of a novel dementia treatment designed to target the T1R3 GPCR. The company is engaged in drug development based on the novel target GPCR TASR platform by establishing an optimization progra...

Healthcare
Seongnam, South Korea
Founded 2020
8 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$10.6M
Last Round
N/A
Investors
+9 other investors
View all 9 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock DigmBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required